Lenalidomide

• Description :

  Lenalidomide (initially known as CC-5013 and marketed as Revlimid? by Celgene) is a derivative of thalidomide introduced in 2004.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  259.26

• Molecular Formula :

  C13H13N3O3

• Notes :

  Research use only, not for human use.

• Receptor :

  TNF-α

• CAS Number :

  191732-72-6